Royalty Pharma plc (RPRX)
NASDAQ$33.41
Market Cap
$14.48B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
818 of 924
Rank in Industry
465 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
RPRX Insider Trading Activity
RPRX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
No records found
About Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies …
Insider Activity of Royalty Pharma plc
Over the last 12 months, insiders at Royalty Pharma plc have bought $0 and sold $0 worth of Royalty Pharma plc stock.
On average, over the past 5 years, insiders at Royalty Pharma plc have bought $50.76M and sold $209.75M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 130,000 shares for transaction amount of $3.84M was made by Legorreta Pablo G. (CEO, Chairman of the Board) on 2023‑06‑28.
List of Insider Buy and Sell Transactions, Royalty Pharma plc
| 2024-01-04 | Sale | RIGGS RORY B | director | 35,702 0.0083% | $27.55 | $983,504 | +1.71% | |
| 2024-01-03 | Sale | RIGGS RORY B | director | 199,098 0.0467% | $27.79 | $5.53M | +1.84% | |
| 2024-01-02 | Sale | RIGGS RORY B | director | 235,200 0.0566% | $28.52 | $6.71M | -0.09% | |
| 2023-12-29 | Sale | Avara Management Ltd | 10 percent owner | 65,803 0.0156% | $28.04 | $1.85M | +0.66% | |
| 2023-12-28 | Sale | Avara Management Ltd | 10 percent owner | 209,863 0.05% | $28.20 | $5.92M | +1.11% | |
| 2023-12-27 | Sale | Avara Management Ltd | 10 percent owner | 41,729 0.0099% | $28.01 | $1.17M | +0.92% | |
| 2023-12-15 | Sale | Avara Management Ltd | 10 percent owner | 10,229 0.0024% | $28.01 | $286,499 | +3.28% | |
| 2023-12-14 | Sale | Avara Management Ltd | 10 percent owner | 364,441 0.0889% | $28.91 | $10.53M | -1.26% | |
| 2023-12-13 | Sale | Avara Management Ltd | 10 percent owner | 307,935 0.0753% | $28.95 | $8.92M | -3.25% | |
| 2023-08-10 | Sale | Coyne Terrance P. | EVP & CFO | 37,500 0.0097% | $30.75 | $1.15M | -6.43% | |
| 2023-08-09 | Sale | Coyne Terrance P. | EVP & CFO | 37,500 0.0097% | $30.72 | $1.15M | -6.25% | |
| 2023-07-13 | Sale | Coyne Terrance P. | EVP & CFO | 37,500 0.0098% | $30.93 | $1.16M | -6.47% | |
| 2023-07-12 | Sale | Coyne Terrance P. | EVP & CFO | 37,500 0.0098% | $31.07 | $1.17M | -8.17% | |
| 2023-06-28 | Legorreta Pablo G. | CEO, Chairman of the Board | 130,000 0.0324% | $29.51 | $3.84M | -2.60% | ||
| 2023-06-13 | Legorreta Pablo G. | CEO, Chairman of the Board | 45,000 0.0125% | $32.78 | $1.47M | -10.40% | ||
| 2023-06-12 | Legorreta Pablo G. | CEO, Chairman of the Board | 45,000 0.0125% | $33.00 | $1.48M | -11.51% | ||
| 2023-06-06 | Sale | Lloyd George W. | EVP, Investments & CLO | 79,099 0.0226% | $33.82 | $2.67M | -14.01% | |
| 2023-06-05 | Sale | Lloyd George W. | EVP, Investments & CLO | 19,215 0.0054% | $33.54 | $644,446 | -12.62% | |
| 2023-06-02 | Sale | Lloyd George W. | EVP, Investments & CLO | 93,907 0.0267% | $33.64 | $3.16M | -12.81% | |
| 2023-05-24 | Legorreta Pablo G. | CEO, Chairman of the Board | 150,000 0.0408% | $32.25 | $4.84M | -9.04% |
Total: 235
Insider Historical Profitability
<0.0001%
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 10 percent owner | 38714280 8.9342% | $1.29B | 1 | 2 | <0.0001% |
| Giuliani Mario Germano | director | 7795072 1.7989% | $260.43M | 1 | 10 | <0.0001% |
| Lappe Mark | 4292136 0.9905% | $143.4M | 10 | 0 | ||
| PERCEPTIVE ADVISORS LLC | 10 percent owner | 2862560 0.6606% | $95.64M | 14 | 3 | |
| Efficacy Capital, Ltd. | 10 percent owner | 2552233 0.589% | $85.27M | 36 | 20 |
Historical Insider Profitability vs. Competitors
$961,890,236 | 276 | 22.46% | $11.68B | |
$211,610,344 | 91 | 38.45% | $7.52B | |
$2,765,836 | 72 | 20.00% | $13.61B | |
$108,876,545 | 67 | 72.81% | $7.92B | |
$2,449,191,716 | 58 | 16.50% | $72.28B |
RPRX Institutional Investors: Active Positions
| Increased Positions | 236 | +55.92% | 32M | +10.34% |
| Decreased Positions | 190 | -45.02% | 24M | -7.6% |
| New Positions | 74 | New | 9M | New |
| Sold Out Positions | 53 | Sold Out | 4M | Sold Out |
| Total Postitions | 468 | +10.9% | 322M | +2.74% |
RPRX Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Morgan Stanley | $1.3M | 9.13% | 39.53M | -2M | -3.76% | 2024-12-31 |
| Vanguard Group Inc | $1.22M | 8.63% | 37.35M | -231,114 | -0.61% | 2024-12-31 |
| Fmr Llc | $864,451.00 | 6.09% | 26.38M | -2M | -5.42% | 2024-12-31 |
| Blackrock, Inc. | $833,882.00 | 5.88% | 25.45M | +3M | +14.1% | 2024-12-31 |
| Adage Capital Partners Gp, L.L.C. | $556,052.00 | 3.92% | 16.97M | +5M | +42.6% | 2024-12-31 |
| Baillie Gifford & Co | $463,188.00 | 3.26% | 14.13M | -2M | -12.33% | 2024-12-31 |
| Viking Global Investors Lp | $400,052.00 | 2.82% | 12.21M | +113,864 | +0.94% | 2024-12-31 |
| Swedbank Ab | $398,620.00 | 2.81% | 12.16M | +1M | +10.31% | 2024-12-31 |
| State Street Corp | $319,841.00 | 2.25% | 9.76M | +243,901 | +2.56% | 2024-12-31 |
| Geode Capital Management, Llc | $239,632.00 | 1.69% | 7.31M | +46,765 | +0.64% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.